KONINKLIJKE PHILIPS NV (PHI1.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:PHI1 • NL0000009538

24.25 EUR
-0.17 (-0.7%)
Last: Jan 29, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PHI1. PHI1 was compared to 63 industry peers in the Health Care Equipment & Supplies industry. PHI1 has a bad profitability rating. Also its financial health evaluation is rather negative. PHI1 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year PHI1 was profitable.
  • In the past year PHI1 had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PHI1 reported negative net income in multiple years.
  • Of the past 5 years PHI1 4 years had a positive operating cash flow.
PHI1.DE Yearly Net Income VS EBIT VS OCF VS FCFPHI1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

  • With a Return On Assets value of 0.63%, PHI1 is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
  • With a Return On Equity value of 1.56%, PHI1 is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
  • With a Return On Invested Capital value of 3.95%, PHI1 is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.63%
ROE 1.56%
ROIC 3.95%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHI1.DE Yearly ROA, ROE, ROICPHI1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.93%, PHI1 is doing worse than 61.90% of the companies in the same industry.
  • PHI1's Operating Margin of 6.10% is in line compared to the rest of the industry. PHI1 outperforms 41.27% of its industry peers.
  • In the last couple of years the Operating Margin of PHI1 has declined.
  • PHI1 has a Gross Margin of 43.49%. This is in the lower half of the industry: PHI1 underperforms 77.78% of its industry peers.
  • In the last couple of years the Gross Margin of PHI1 has remained more or less at the same level.
Industry RankSector Rank
OM 6.1%
PM (TTM) 0.93%
GM 43.49%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHI1.DE Yearly Profit, Operating, Gross MarginsPHI1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHI1 is destroying value.
  • PHI1 has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, PHI1 has more shares outstanding
  • PHI1 has a worse debt/assets ratio than last year.
PHI1.DE Yearly Shares OutstandingPHI1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHI1.DE Yearly Total Debt VS Total AssetsPHI1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • PHI1 has an Altman-Z score of 1.97. This is not the best score and indicates that PHI1 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of PHI1 (1.97) is comparable to the rest of the industry.
  • The Debt to FCF ratio of PHI1 is 14.51, which is on the high side as it means it would take PHI1, 14.51 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 14.51, PHI1 is doing worse than 60.32% of the companies in the same industry.
  • PHI1 has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHI1 is somewhat dependend on debt financing.
  • PHI1 has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: PHI1 underperforms 73.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 14.51
Altman-Z 1.97
ROIC/WACC0.6
WACC6.58%
PHI1.DE Yearly LT Debt VS Equity VS FCFPHI1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.32 indicates that PHI1 should not have too much problems paying its short term obligations.
  • The Current ratio of PHI1 (1.32) is comparable to the rest of the industry.
  • A Quick Ratio of 0.86 indicates that PHI1 may have some problems paying its short term obligations.
  • The Quick ratio of PHI1 (0.86) is worse than 65.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.86
PHI1.DE Yearly Current Assets VS Current LiabilitesPHI1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 15.15% over the past year.
  • The Earnings Per Share has been decreasing by -7.17% on average over the past years.
  • Looking at the last year, PHI1 shows a decrease in Revenue. The Revenue has decreased by -1.43% in the last year.
  • Measured over the past years, PHI1 shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%

3.2 Future

  • Based on estimates for the next years, PHI1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.28% on average per year.
  • PHI1 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.00% yearly.
EPS Next Y4.94%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PHI1.DE Yearly Revenue VS EstimatesPHI1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHI1.DE Yearly EPS VS EstimatesPHI1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.39, PHI1 is valued correctly.
  • PHI1's Price/Earnings ratio is rather cheap when compared to the industry. PHI1 is cheaper than 93.65% of the companies in the same industry.
  • PHI1 is valuated rather cheaply when we compare the Price/Earnings ratio to 28.39, which is the current average of the S&P500 Index.
  • PHI1 is valuated correctly with a Price/Forward Earnings ratio of 15.94.
  • Based on the Price/Forward Earnings ratio, PHI1 is valued a bit cheaper than the industry average as 74.60% of the companies are valued more expensively.
  • PHI1's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.72.
Industry RankSector Rank
PE 16.39
Fwd PE 15.94
PHI1.DE Price Earnings VS Forward Price EarningsPHI1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PHI1 is valued a bit cheaper than 69.84% of the companies in the same industry.
  • PHI1's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 40.4
EV/EBITDA 12.83
PHI1.DE Per share dataPHI1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.32
PEG (5Y)N/A
EPS Next 2Y4.81%
EPS Next 3Y7.44%

0

5. Dividend

5.1 Amount

  • PHI1 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

KONINKLIJKE PHILIPS NV / PHI1.DE FAQ

What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE.


What is the valuation status for PHI1 stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHI1.DE). This can be considered as Fairly Valued.


How profitable is KONINKLIJKE PHILIPS NV (PHI1.DE) stock?

KONINKLIJKE PHILIPS NV (PHI1.DE) has a profitability rating of 2 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 2 / 10.


Can you provide the dividend sustainability for PHI1 stock?

The dividend rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 0 / 10 and the dividend payout ratio is 199.39%.